10x Genomics, Inc. Debt Securities, Available-for-sale, Realized Loss
10x Genomics, Inc. (TXG) reported Debt Securities, Available-for-sale, Realized Loss of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Income Statement › Other Income
us-gaap:DebtSecuritiesAvailableForSaleRealizedLoss · last filed 2026-02-13
- 10x Genomics, Inc. debt securities, available-for-sale, realized loss for the quarter ending 2023-12-31 was -$3.40M.
- 10x Genomics, Inc. debt securities, available-for-sale, realized loss for the quarter ending 2023-09-30 was $1.70M.
- 10x Genomics, Inc. debt securities, available-for-sale, realized loss for the quarter ending 2023-06-30 was $1.70M.
- 10x Genomics, Inc. debt securities, available-for-sale, realized loss for the quarter ending 2023-03-31 was $1.70M.
- 10x Genomics, Inc. debt securities, available-for-sale, realized loss for fiscal 2025 was $0.00.
- 10x Genomics, Inc. debt securities, available-for-sale, realized loss for fiscal 2024 was $0.00.
- 10x Genomics, Inc. debt securities, available-for-sale, realized loss for fiscal 2023 was -$1.70M.
| Period end | Debt Securities, Available-for-sale, Realized Loss 3 month | Debt Securities, Available-for-sale, Realized Loss 3 month as first filed | Debt Securities, Available-for-sale, Realized Loss 6 month | Debt Securities, Available-for-sale, Realized Loss 9 month | Debt Securities, Available-for-sale, Realized Loss 12 month | Debt Securities, Available-for-sale, Realized Loss 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-13 | |||||
| 2024-12-31 | $0.00 10-K · filed 2026-02-13 | -$3.00K 10-K · filed 2025-02-13 | ||||
| 2023-12-31 | -$3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$1.70M derived: sum of 2 quarters · filed 2026-02-13 | $0.00 derived: sum of 3 quarters · filed 2026-02-13 | -$1.70M 10-K · filed 2026-02-13 | ||
| 2023-09-30 | $1.70M 10-Q · filed 2024-10-29 | $0.00 10-Q · filed 2023-11-03 | $3.40M derived: sum of 2 quarters · filed 2024-10-29 | $1.70M 10-Q · filed 2024-10-29 | ||
| 2023-06-30 | $1.70M 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2023-08-04 | $1.70M 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | $1.70M 10-Q · filed 2024-04-30 | |||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-03 | $0.00 derived: sum of 2 quarters · filed 2023-11-03 | $0.00 10-Q · filed 2023-11-03 | |||
| 2022-06-30 | $0.00 10-Q · filed 2023-08-04 | $0.00 10-Q · filed 2023-08-04 | ||||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 |